These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1493851

  • 21. Sabeluzole (R58 735) increases consistent retrieval during serial learning and relearning of nonsense syllables.
    Clincke GH, Tritsmans L.
    Psychopharmacology (Berl); 1988; 96(3):309-10. PubMed ID: 3146765
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers.
    Wilner KD, Tensfeldt TG, Baris B, Smolarek TA, Turncliff RZ, Colburn WA, Hansen RA.
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):15S-20S. PubMed ID: 10771449
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA, Marbury T, Matsushima N, Chen S, Wickremasingha PK, He L, Dishy V, Brown KS.
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment.
    Noveck RJ, Preston RA, Swan SK.
    Clin Pharmacokinet; 2007 Apr; 46(6):525-34. PubMed ID: 17518511
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers.
    Silvasti M, Karttunen P, Tukiainen H, Mykkänen M, Hänninen U, Välttilä S.
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390
    [Abstract] [Full Text] [Related]

  • 28. Levormeloxifene: safety, pharmacodynamics and pharmacokinetics in healthy postmenopausal women following single and multiple doses of a new selective oestrogen receptor modulator.
    Skrumsager BK, Kiehr B, Pedersen PC, Gerrits M, Watson N, Bjarnason K.
    Br J Clin Pharmacol; 2002 Mar; 53(3):284-95. PubMed ID: 11874392
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food.
    Lamba M, Wang R, Fletcher T, Alvey C, Kushner J, Stock TC.
    J Clin Pharmacol; 2016 Nov; 56(11):1362-1371. PubMed ID: 26970526
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses.
    Fredholm DV, Carpenter JW, KuKanich B, Kohles M.
    Am J Vet Res; 2013 Apr; 74(4):636-41. PubMed ID: 23531074
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
    Parnetti L, Gaiti A, Mecocci P, Cadini D, Senin U.
    Eur J Clin Pharmacol; 1992 Apr; 42(1):89-93. PubMed ID: 1541322
    [Abstract] [Full Text] [Related]

  • 35. Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration.
    Bethke TH, Merz M, Zech K, Seiberling M, Hauschke D, Heinze H, Wurst W.
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):259-64. PubMed ID: 11430634
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
    Stass H, Kubitza D, Schühly U.
    Clin Pharmacokinet; 2001 Jun; 40 Suppl 1():1-9. PubMed ID: 11352436
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone.
    Upton RA, Knutson JC, Bishop CW, LeVan LW.
    Nephrol Dial Transplant; 2003 Apr; 18(4):750-8. PubMed ID: 12637645
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics, pharmacodynamics and tolerability of a potent, non-peptidic, GP IIb/IIIa receptor antagonist following multiple oral administrations of a prodrug form.
    Refino CJ, Modi NB, Bullens S, Pater C, Lipari MT, Robarge K, Blackburn B, Beresini M, Weller T, Steiner B, Bunting S.
    Thromb Haemost; 1998 Jan; 79(1):169-76. PubMed ID: 9459344
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.